Xiaokun Li
Impact in
- Molecular Medicine top 0.2%
- Curcumin's Biomedical Applications
- Rehabilitation top 0.2%
- Wound Healing and Treatments
Papers in
-
- Fibroblast Growth Factor Research 216
- Kruppel-like factors research 91
- Epigenetics and DNA Methylation 67
-
- Curcumin's Biomedical Applications 23
Xiaokun Li
544 papers receiving 20.9k citations
Hit Papers
Peers
Comparison fields: 5 of 182
- Molecular Medicine 1.2k
- Rehabilitation 1.3k
- Molecular Biology 10.1k
- Nephrology 719
- Developmental Neuroscience 414
Countries citing papers authored by Xiaokun Li
This map shows the geographic impact of Xiaokun Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaokun Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaokun Li more than expected).
Fields of papers citing papers by Xiaokun Li
This network shows the impact of papers produced by Xiaokun Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaokun Li. The network helps show where Xiaokun Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaokun Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 8 | |
| 8 | 2023 | 15 | |
| 9 | 2022 | 17 | |
| 10 | 2022 | 29 | |
| 11 | 2022 | 12 | |
| 12 | 2022 | 8 | |
| 13 | 2021 | 81 | |
| 14 | 2021 | 54 | |
| 15 | 2021 | 5 | |
| 16 | 2020 | 17 | |
| 17 | 2020 | 0 | |
| 18 | 2017 | 10 | |
| 19 | 2011 | 24 | |
| 20 | The stability of recombinant human acid fibroblast growth factor | 2006 | 1 |
About Xiaokun Li
Xiaokun Li is a scholar working on Molecular Biology, Molecular Medicine, Rehabilitation, Cell Biology and Cancer Research, having authored 559 papers that have together received 21.2k indexed citations. Recurring topics across this work include Fibroblast Growth Factor Research (216 papers), Kruppel-like factors research (91 papers), Epigenetics and DNA Methylation (67 papers), Cancer, Hypoxia, and Metabolism (32 papers), Wound Healing and Treatments (31 papers), Nerve injury and regeneration (24 papers), Proteoglycans and glycosaminoglycans research (23 papers) and Curcumin's Biomedical Applications (23 papers). The work is most often cited by research in Molecular Medicine (1.2k citations), Rehabilitation (1.3k citations), Molecular Biology (10.1k citations), Nephrology (719 citations) and Developmental Neuroscience (414 citations). Xiaokun Li has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Jian Xiao, Lu Cai, Guang Liang, Yi Tan, Hongyu Zhang, Zhouguang Wang, Wenke Feng, Zhuofeng Lin, Shulin Yang and Xiaobing Fu. Their work appears in journals such as Journal of Cellular and Molecular Medicine, PLoS ONE, Applied Microbiology and Biotechnology, Frontiers in Cell and Developmental Biology and Protein Expression and Purification.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.